Welcome to the IDT family!

Your product is now available from Integrated DNA Technologies.

Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.

xGen NGS—made for you.

Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.

Integrated DNA Technologies acquires Archer™ next generation sequencing research assays to advance actionable scientific discoveries.

Functional genomics

An ASO modification that enhances nuclease resistance, lowers toxicity, and increases binding affinity

2′-MOE bases are often included in antisense oligos (ASO), aptamers, and siRNAs. Use them in place of standard RNA bases to increase nuclease resistance, reduce nonspecific protein binding, and to increase binding affinity with targeted complementary RNA.

  • An ASO modification that enhances nuclease resistance, lowers toxicity, and increases binding affinity
  • A mutant A.s. Cas12a (Cpf1) for CRISPR genome editing shows broad temperature tolerance and a high ratio of on:off target activity, with site-to-site reliability rivaling S.p. Cas9
  • Antisense Oligonucleotides (ASOs)
  • Oligo modifications that block nuclease degradation

DECODED online newsletter

Sign up now

DECODED article categories:

  • Custom DNA & RNA
  • Coronavirus
  • CRISPR genome editing
  • Next generation sequencing
  • Genes & gene fragments
  • qPCR & PCR
  • Functional genomics